SD Biosensor

SD Biosensor Goodwill

The Goodwill of SD Biosensor (137310.KS) as of Oct 20, 2026 is 784.97 B KRW. In the previous year, Goodwill was 1.37 T KRW — a change of -42.76% (lower).

Goodwill

784.97 BKRW

YoY

-42.76%

Last updated:

Goodwill of SD Biosensor is 2025 784.97 B KRW. Goodwill of SD Biosensor was 2024 1.37 T KRW. It decreases by -42.76% lower compared to the previous year.

The SD Biosensor Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2019
5.06 B KRW
Jan 1, 2020
4.87 B KRW
Jan 1, 2021
35.32 B KRW
Jan 1, 2022
44.00 B KRW
Jan 1, 2023
1.21 T KRW
Jan 1, 2024
1.37 T KRW
Jan 1, 2025
784.97 B KRW
The SD Biosensor Goodwill history
YEARGoodwillYoY
784.97 BKRW-42.76%
1.37 TKRW+13.18%
1.21 TKRW+2,653.49%
44.00 BKRW+24.59%
35.32 BKRW+625.67%
4.87 BKRW-3.88%
5.06 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SD Biosensor stock

Goodwill of SD Biosensor is 784.97 B KRW in 2025.

Goodwill of SD Biosensor changed from 1.37 T KRW to 784.97 B KRW, representing a -42.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's SD Biosensor historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SD Biosensor

All Key Metrics — SD Biosensor